ProShares UltraShort Nasdaq Biotechnology BIS
10.62 USD -0.11 (-1.03%)
At closeNov 3, 2026, 4:00 PM EST
10.53 -0.09 -0.84%
After hours · Nov 3, 4:00 PM ET
10.26 Day range 10.73
10.06 52-week range 22.98
- YTD
- -43.99%
- 1 year
- -52.34%
- Market cap
- 1.78M
- YTD return
- -43.99%
- 1-year return
- -52.34%
- Volume
- 5.36K
- Avg volume
- 9.43K
- Open
- 10.50
- Previous close
- 10.73
- Day's range
- 10.26 – 10.73
- 52-week range
- 10.06 – 22.98
2Y -20.60 (-66.45%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 16.07
- 200-day average
- 16.53
About ProShares UltraShort Nasdaq Biotechnology
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
News
TD Touts Successful Tokenized Payments With Project Agorá 
BIS says AI boom risks clouding central banks' inflation signals 
BIS dares to blaspheme as AI bubble fears wane 
BIS says debt, AI boom and fragilities raise global risks 
Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules 
Retail traders using leveraged ETFs were a major driver of January's dramatic gold and silver selloff – BIS 
Applied Materials Reaches Resolution with the U.S. Department of Commerce 
BIS says gold and equities are in bubble territory 
Central bank body BIS raises concerns of gold and stocks double bubble 
Can Energy Transfer Gain From BIS' Current Stance on Ethane Export?
Your note
Sign in to keep a note on BIS — it syncs with the Stock Master app.